©The Author(s) 2017.
World J Hematol. Feb 6, 2017; 6(1): 11-16
Published online Feb 6, 2017. doi: 10.5315/wjh.v6.i1.11
Published online Feb 6, 2017. doi: 10.5315/wjh.v6.i1.11
Table 3 Treatment recommendations amongst different types of disseminated intravascular coagulation
| Dysfunction | Recommended treatment |
| Pre-DIC | Treat cause and |
| UFH 70 IU/kg per day or | |
| LWMH anti-Xa target: 0.8-1.2 | |
| Multiple organ failure | Treat cause and |
| AT 30 IU/kg per day of 3 d | |
| Hemorrhagic | Treat cause and |
| Hemo-transfusion | |
| Anti-fibrinolytics | |
| Protease synthetic inhibitor | |
| Massive hemorrhage | Treat cause and |
| Hemo-transfusion | |
| Anti-fibrinolytics | |
| Protease synthetic inhibitor |
- Citation: Zaragoza JJ, Espinoza-Villafuerte MV. Current approach to disseminated intravascular coagulation related to sepsis - organ failure type. World J Hematol 2017; 6(1): 11-16
- URL: https://www.wjgnet.com/2218-6204/full/v6/i1/11.htm
- DOI: https://dx.doi.org/10.5315/wjh.v6.i1.11